Tiratricol, Matching placebo (for participants allocated to the placebo group in the clinical trials

Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency): A Doubleblind, Randomized, Placebocontrolled Study (MCT8-2021-3 (ReTRIACt))

This study looks at what happens if a medicine called Tiratricol is stopped in men with MCT8 deficiency. It aims to see how their T3 hormone levels change and if they stay within a healthy range after stopping the treatment.